CONCLUSIONS: MPH remains a well-studied, effective, and generally well-tolerated treatment for ADHD in children, adolescents, and adults. The diversity of available formulations, including novel delivery systems such as delayed-release/extended-release MPH and serdexmethylphenidate/dexmethylphenidate, allows for individualized treatment matched to patient needs and daily functional demands. Clinicians who understand evidence-based rebuttals to myths about MPH can improve prescribing decisions…
